A law firm <a href=" http://weimar.edu/best-book-review-writer/#love ">research paper order exhibits</a> Prosensa developed drisapersen in partnership with GlaxoSmithKline Plc to treat Duchenne Muscular Dystrophy (DMD), a muscle-wasting disorder that affects one in every 3,500 newborn boys and has no available cure.
| # | Item | Wins | Losses | Wins + Losses | Score |
|---|---|---|---|---|---|
| 1 | A law firm <a href=" http://weimar.edu/best-book-review-writer/#love ">research paper order exhibits</a> Prosensa developed drisapersen in partnership with GlaxoSmithKline Plc to treat Duchenne Muscular Dystrophy (DMD) | 0 | 0 | 0 | 0 |
| 2 | a muscle-wasting disorder that affects one in every 3 | 0 | 0 | 0 | 0 |
| 3 | 500 newborn boys and has no available cure. | 0 | 0 | 0 | 0 |
Back to the polls!